Onconetix, Inc. Files 8-K with Material Agreements and Officer Changes
Ticker: ONCO · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1782107
Sentiment: neutral
Topics: material-agreement, management-change, corporate-action
Related Tickers: ONCO
TL;DR
Onconetix (ONCO) filed an 8-K detailing new deals and exec changes. Watch closely.
AI Summary
Onconetix, Inc. filed an 8-K on July 16, 2025, reporting on several key events. These include entering into a material definitive agreement, changes in directors and officers, and other significant events. The filing also covers financial statements and exhibits, with the company previously known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc.
Why It Matters
This 8-K filing signals significant corporate activity at Onconetix, Inc., potentially impacting its strategic direction, leadership, and financial reporting.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, requiring careful investor attention.
Key Players & Entities
- Onconetix, Inc. (company) — Registrant
- Blue Water Biotech, Inc. (company) — Former company name
- Blue Water Vaccines Inc. (company) — Former company name
- July 16, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Onconetix, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What specific changes occurred regarding directors or certain officers?
The filing lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' as an item of information, but the specifics are not detailed in the provided text.
When did Onconetix, Inc. change its name from Blue Water Biotech, Inc.?
The date of the name change from Blue Water Biotech, Inc. to Onconetix, Inc. was April 24, 2023.
What is the SEC file number for Onconetix, Inc.?
The SEC file number for Onconetix, Inc. is 001-41294.
What is the primary business of Onconetix, Inc. according to its SIC code?
Onconetix, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Onconetix, Inc. (ONCO).